Zurich Cantonal Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Sell |
|
|||||
|
2025
Q1 | $15.4M | Buy |
|
|||||
|
2024
Q4 | $12.8M | Sell |
|
|||||
|
2024
Q3 | $15M | Sell |
|
|||||
|
2024
Q2 | $15.9M | Buy |
|
|||||
|
2024
Q1 | $7.47M | Buy |
|
|||||
|
2023
Q4 | $8.63M | Buy |
|
|||||
|
2023
Q3 | $4M | Buy |
|
|||||
|
2023
Q2 | $3.88M | Buy |
|
|||||
|
2023
Q1 | $4M | Buy |
|
|||||
|
2022
Q4 | $4.49M | Sell |
|
|||||
|
2022
Q3 | $9.26M | Buy |
|
|||||
|
2022
Q2 | $6.72M | Buy |
|
|||||
|
2022
Q1 | $3.01M | Buy |
|
|||||
|
2021
Q4 | $3.1M | Sell |
|
|||||
|
2021
Q3 | $5.12M | Buy |
|
|||||
|
2021
Q2 | $4.46M | Sell |
|
|||||
|
2021
Q1 | $3.72M | Buy |
|
|||||
|
2020
Q4 | $3.38M | Buy |
|
|||||
|
2020
Q3 | $3.77M | Buy |
|
|||||
|
2020
Q2 | $3.48M | Sell |
|
|||||
|
2020
Q1 | $2.67M | Buy |
|
|||||
|
2019
Q4 | $2.7M | Buy |
|
|||||
|
2019
Q3 | $1.48M | Buy |
|
|||||
|
2019
Q2 | $1.26M | Sell |
|
|||||
|
2019
Q1 | $1.68M | Sell |
|
|||||
|
2018
Q4 | $1.33M | Sell |
|
|||||
|
2018
Q3 | $1.63M | Buy |
|
|||||
|
2018
Q2 | $1.8M | Sell |
|
|||||
|
2018
Q1 | $2.39M | Buy |
|
|||||
|
2017
Q4 | $2.5M | Buy |
|
|||||
|
2017
Q3 | $612K | Buy |
|
|||||
|
2017
Q2 | $280K | Buy |
|
|||||
|
2017
Q1 | $148K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $993K | Buy |
|
|||||
|
2016
Q2 | $513K | Buy |
|
|||||
|
2016
Q1 | $521K | Hold |
|
|||||
|
2015
Q4 | $782K | Buy |
|
|||||
|
2015
Q3 | $511K | Buy |
|
|||||
|
2015
Q2 | $650K | Buy |
|
|||||
|
2015
Q1 | $543K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $781K | Sell |
|
|||||
|
2014
Q2 | $3.79M | Buy |
|
|||||
|
2014
Q1 | $1.54M | Hold |
|
|||||
|
2013
Q4 | $1.48M | Buy |
|
|||||
|
2013
Q3 | $1.34M | Buy |
|